COMBINATION THERAPY WITH INTERLEUKIN-2 AND ALPHA-INTERFERON FOR THE TREATMENT OF PATIENTS WITH ADVANCED CANCER

被引：367

作者：

ROSENBERG, SA

LOTZE, MT

YANG, JC

LINEHAN, WM

SEIPP, C

CALABRO, S

KARP, SE

SHERRY, RM

STEINBERG, S

WHITE, DE

机构：

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1989年 / 7卷 / 12期

关键词：

D O I：

10.1200/JCO.1989.7.12.1863

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1863 / 1874

页数：12

相关论文

共 50 条

[1] ENHANCEMENT OF FC-GAMMA RECEPTOR EXPRESSION IN INTERFERON-TREATED MICE
AGUET, M
VIGNAUX, F
FRIDMAN, WH
GRESSER, I
[J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (11) : 926 - 930
[2] INVIVO ANTITUMOR-ACTIVITY OF COMBINATIONS OF INTERFERON-ALPHA AND INTERLEUKIN-2 IN A MURINE MODEL - CORRELATION OF EFFICACY WITH THE INDUCTION OF CYTOTOXIC-CELLS RESEMBLING NATURAL-KILLER-CELLS
BRUNDA, MJ
BELLANTONI, D
SULICH, V
[J]. INTERNATIONAL JOURNAL OF CANCER, 1987, 40 (03) : 365 - 371
[3] CAMERON RB, 1988, CANCER RES, V48, P5810
[4] AUGMENTATION OF THE ANTI-TUMOR THERAPEUTIC EFFICACY OF LONG-TERM CULTURED LYMPHOCYTES-T BY INVIVO ADMINISTRATION OF PURIFIED INTERLEUKIN-2
CHEEVER, MA
GREENBERG, PD
FEFER, A
GILLIS, S
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (04) : 968 - 980
[5] MACROPHAGE ACTIVATION BY INTERFERON ALPHA+BETA IS ASSOCIATED WITH A LOSS OF PROLIFERATIVE CAPACITY - ROLE OF INTERFERON ALPHA+BETA IN THE REGULATION OF MACROPHAGE PROLIFERATION AND FUNCTION
CHEN, BDM
NAJOR, F
[J]. CELLULAR IMMUNOLOGY, 1987, 106 (02) : 343 - 354
[6] CLASON AE, 1982, J IMMUNOL, V129, P252
[7] RECOMBINANT INTERFERONS IN THE MANAGEMENT OF ADVANCED MALIGNANT-MELANOMA - UPDATED REVIEW OF 5 PROSPECTIVE CLINICAL-TRIALS AND LONG-TERM RESPONDERS
CREAGAN, ET
SCHAID, DJ
AHMANN, DL
FRYTAK, S
[J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (06): : 652 - 659
[8] DUTCHER JP, 1987, P AN M AM SOC CLIN, V6, P246
[9] EVANS SS, 1987, J IMMUNOL, V138, P2451
[10] FERTSCH D, 1987, J IMMUNOL, V139, P244

← 1 2 3 4 5 →